Vericel CorpVCELEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 16.60% | 7.9M | — | 2024-01-22 |
| NOS. OF ABOVE PERSONS | 7.80% | 3.8M | ▼ -1.29pp | 2024-11-14 |
| The Vanguard Group | 7.07% | 3.4M | — | 2024-02-13 |
| Conestoga Capital Advisors LLC | 5.23% | 2.5M | — | 2024-01-05 |
| STATE STREET CORPORATION | 5.00% | 2.4M | ▼ -0.58pp | 2024-10-18 |
| RTW Investments, LP | 0.00% | 92.3K | ▼ -6.70pp | 2024-11-14 |
Insider Transactions
Net 90d: −$1.97M · buys $0 / sells $1.97MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-02 | Hopper Jonathan Mark | Chief Medical Officer | Option exercise | 3.5K | $10.95 | $38.0K |
| 2026-04-02 | Hopper Jonathan Mark | Chief Medical Officer | Sell (open market) | 3.5K | $35.00 | $121.5K |
| 2026-03-25 | Rubino Alan L | Director | Option exercise | 15.0K | $2.76 | $41.4K |
| 2026-03-23 | Heidi Hagen | Director | Option exercise | 15.0K | $2.76 | $41.4K |
| 2026-03-23 | Heidi Hagen | Director | Sell (open market) | 15.0K | $32.41 | $486.1K |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Sell (open market) | 6.4K | $34.75 | $223.1K |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Option exercise | 15.0K | $16.25 | $243.8K |
| 2026-03-02 | Flynn Sean C. | Chief Legal Officer | Sell (open market) | 15.0K | $35.36 | $530.4K |
| 2026-03-02 | Michael Halpin | Chief Operating Officer | Sell (open market) | 10.3K | $35.30 | $363.8K |
| 2026-02-24 | Dominick Colangelo | President and CEO | Option exercise | 18.3K | — | — |
1–10 of 37
Page 1 / 4